Compare TECH & GATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TECH | GATX |
|---|---|---|
| Founded | 1976 | 1898 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 7.0B |
| IPO Year | 1995 | 1994 |
| Metric | TECH | GATX |
|---|---|---|
| Price | $55.12 | $198.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 2 |
| Target Price | $71.82 | ★ $215.50 |
| AVG Volume (30 Days) | ★ 1.9M | 174.7K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | 0.59% | ★ 1.33% |
| EPS Growth | N/A | ★ 17.22 |
| EPS | 0.49 | ★ 9.12 |
| Revenue | $1,219,635,000.00 | ★ $1,740,400,000.00 |
| Revenue This Year | $2.49 | $42.21 |
| Revenue Next Year | $6.40 | $3.35 |
| P/E Ratio | $110.17 | ★ $21.71 |
| Revenue Growth | 5.23 | ★ 9.77 |
| 52 Week Low | $46.05 | $141.28 |
| 52 Week High | $72.16 | $205.56 |
| Indicator | TECH | GATX |
|---|---|---|
| Relative Strength Index (RSI) | 47.99 | 69.19 |
| Support Level | $49.55 | $166.88 |
| Resistance Level | $58.04 | $199.00 |
| Average True Range (ATR) | 2.58 | 3.80 |
| MACD | -0.23 | 0.69 |
| Stochastic Oscillator | 35.05 | 70.27 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
GATX Corp leases transportation assets, including railcars, aircraft spare engines, and tank containers, to customers in North America, Europe, and India. The company's reportable business segments are: Rail North America, Rail International, Engine Leasing, and Other. The majority of its revenue is generated from the Rail North America segment, which is composed of the company's operations in the United States, Canada, and Mexico. This segment mainly provides railcars pursuant to full-service leases under which it maintains the railcars, pays ad valorem taxes and insurance, and provides other ancillary services.